SLC35A2 and melanoma: If knocking down one UGT by ∼60% sensitized melanoma cells to adriamycin and epirubicin then it stands to reason that the IC50 for WM3211 melanoma cells (which lack UGT expression) would be significantly lower than WM115 parental cells (which have UGT expression).